Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
I am interested in...
Wayfinder menu
Find a Physician
News and Updates
Ways to Give
Neurology
Explore this Website
I am interested in...
Wayfinder menu
Find a Physician
News and Updates
Ways to Give
Home
About Us
Toggle About Us menu options
Leadership Directory
News and Updates
Events
Affiliated Institutions
Speakers Bureau
Videos
Contact Us
Ways to Give
Patient Care
Education
Toggle Education menu options
Medical School Neurology Curriculum
Residency
Toggle Residency menu options
Residency Education Leadership
Our Residents
Program Highlights
Resident Research and Educator Track
Resident Publications
Where Are Our Residents Now?
Rotation Sites
Teaching Program
Rotations Schedule
Neurology Subspecialties
New York City
Housing and Stipends
Apply to Residency Program
Fellowship Training
Toggle Fellowship Training menu options
Clinical Neurophysiology Fellowship
Epilepsy Fellowship
Neurocritical Care Fellowship
Vascular Neurology Fellowship
Neurooncology Fellowship
Headache Fellowship
Multiple Sclerosis Fellowship
Grand Rounds
Continuing Medical Education
Educator Development
Education Scholarship
Research
Toggle Research menu options
Clinical Trials
Publications
Women's Brain Initiative
Brain and Nerve Stimulation Program
Diversity and Community Outreach
Toggle Diversity and Community Outreach menu options
Diversity
Community Outreach
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Patient Care
Education
Research
Diversity and Community Outreach
Home
Biblio
Found 7 results
Filters:
Author
is
Fox, Robert J
[Clear All Filters]
2023
Perumal J
,
Balabanov R
,
Balcer L
,
Galetta S
,
Sun Z
,
Li H
,
Rutledge D
,
Avila RL
,
Fox RJ
. 2023.
Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.
.
Neurol Ther. 12(3):833-848.
2022
Perumal J
,
Balabanov R
,
Su R
,
Chang R
,
Balcer LJ
,
Galetta SL
,
Avila RL
,
Rutledge D
,
Fox RJ
. 2022.
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.
.
CNS Drugs. 36(9):977-993.
2021
Perumal J
,
Balabanov R
,
Su R
,
Chang R
,
Balcer L
,
Galetta S
,
Campagnolo DI
,
Avila R
,
Lee L
,
Rutledge D
et al.
. 2021.
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.
.
Adv Ther. 38(7):3724-3742.
2019
Perumal J
,
Fox RJ
,
Balabanov R
,
Balcer LJ
,
Galetta S
,
Makh S
,
Santra S
,
Hotermans C
,
Lee L
. 2019.
Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.
.
BMC Neurol. 19(1):116.
2018
Fox RJ
,
Coffey CS
,
Conwit R
,
Cudkowicz ME
,
Gleason T
,
Goodman A
,
Klawiter EC
,
Matsuda K
,
McGovern M
,
Naismith RT
et al.
. 2018.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
.
N Engl J Med. 379(9):846-855.
2016
Fox RJ
,
Coffey CS
,
Cudkowicz ME
,
Gleason T
,
Goodman A
,
Klawiter EC
,
Matsuda K
,
McGovern M
,
Conwit R
,
Naismith R
et al.
. 2016.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
.
Contemp Clin Trials. 50:166-77.
Goodin DS
,
Reder AT
,
Bermel RA
,
Cutter GR
,
Fox RJ
,
John GR
,
Lublin FD
,
Lucchinetti CF
,
Miller AE
,
Pelletier D
et al.
. 2016.
Relapses in multiple sclerosis: Relationship to disability.
.
Mult Scler Relat Disord. 6:10-20.